Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
Status:
Terminated
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of the combination of
Gliadel wafers plus surgery and limited field radiation therapy with concomitant temozolomide
followed by temozolomide given at an extended dose schedule (metronomic schedule) in patients
undergoing initial surgery for newly-diagnosed high grade glioma.